Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“We summarized the guideline recs for anticoagulant and antiplatelettherapy in ACS and compared them with prior recs in ACCinTouch, AHAScience and escardio guidelines. Writing Committee and also a great team who made this summary possible.”
Title: Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations
Auhors: Behnood Bikdeli, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, Renato D. Lopes, Harvey D. White, Philippe Gabriel Steg, Gregory Piazza, Rasha K. Al-Lamee, David J. Cohen, Roxana Mehran, and Harlan M. Krumholz
Read the full article here.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia